SanjeevanV Kalavampara

Amrita Institute of Medical Sciences and Research Centre

Papers

1

Total Citations

9

H-Index

1

About

Dr. Sanjeevan V. Kalavampara is a distinguished urological surgeon whose research centers on prostate cancer management, particularly in high-risk populations. His major contribution lies in evaluating surgical outcomes for high-risk prostate cancer (HRCaP) in the Indian demographic, challenging conventional treatment paradigms. His most cited work, a 2018 study on pathological outcomes and biochemical recurrence-free survival after radical prostatectomy, analyzed patients classified by D’Amico criteria, demonstrating that surgery can achieve favorable oncologic control even in this challenging cohort. With 9 citations, this paper has informed clinical decision-making in resource-limited settings. Dr. Kalavampara’s research emphasizes the importance of risk stratification—examining factors like cT2c-T3b staging—to optimize surgical candidacy. His work has helped bridge gaps in evidence-based urological oncology for South Asian populations, influencing both surgical practice and postoperative surveillance strategies. Through his dedicated focus on prostate cancer outcomes, he continues to advance the field of urological oncology in India.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Pathological outcomes and biochemical recurrence-free survival after radical prostatectomy for high-risk prostate cancer in the Indian population
9 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Amrita Institute of Medical Sciences and Research Centre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago